Reference

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. The Journal of urology. 1994;151(1):54-61. Epub 1994/01/01.
2. Montague DK, Jarow JP, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al. Chapter 1: The management of erectile dysfunction: an AUA update. The Journal of urology. 2005;174(1):230-9. Epub 2005/06/11.
3. Mazzilli, R.; Zamponi, V.; Olana, S.; Mikovic, N.; Cimadomo, D.; Defeudis, G.; Faggiano, A. Erectile dysfunction as a marker of endocrine and glycemic disorders. J. Endocrinol. Investig. 2022, 45, 1527–1534.
4. Mazzilli, R.; Angeletti, G.; Olana, S.; Delfino, M.; Zamponi, V.; Rapinesi, C.; Del Casale, A.; Kotzalidis, G.D.; Elia, J.; Callovini, G.; et al. Erectile dysfunction in patients taking psychotropic drugs and treated with phosphodiesterase-5 inhibitors. Arch. Ital. Urol. Androl. 2018, 90, 44–48.
5. Gandaglia, G.; Briganti, A.; Jackson, G.; Kloner, R.A.; Montorsi, F.; Montorsi, P.; Vlachopoulos, C. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur. Urol. 2014, 65, 968–978.
6. Fedele, D.; Coscelli, C.; Santeusanio, F.; Bortolotti, A.; Chatenoud, L.; Colli, E.; Landoni, M.; Parazzini, F. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 1998, 21, 1973–1977.
7. Rastrelli, G.; Corona, G.; Mannucci, E.; Maggi, M. Vascular and Chronological Age in Men with Erectile Dysfunction: A Longitudinal Study. J. Sex. Med. 2016, 13, 200–208.
8. V.; Mazzilli, R.; Bitterman, O.; Olana, S.; Iorio, C.; Festa, C.; Giuliani, C.; Mazzilli, F.; Napoli, A. Association between type 1 diabetes and female sexual dysfunction. BMC Women’s Health 2020, 20, 73.
9. La Vignera, S.; Condorelli, R.A.; Cannarella, R.; Giacone, F.; Mongioi’, L.M.; Cimino, L.; DeFeudis, G.; Mazzilli, R.; Calogero, A.E. Urogenital infections in patients with diabetes mellitus: Beyond the conventional aspects. Int. J. Immunopathol. Pharmacol. 2019, 33, 2058738419866582
10. Rosen, R.C.; Riley, A.; Wagner, G.; Osterloh, I.H.; Kirkpatrick, J.; Mishra, A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49, 822–830.
11. Frank, E.; Anderson, C.; Rubinstein, D. Frequency of sexual dysfunction in “normal” couples. N. Engl. J. Med. 1978, 299, 111–115
12. Shah J. Erectile dysfunction through the ages. BJU international. 2002;90(4):433-41. Epub 2002/08/15.
13. McMahon C. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. The journal of sexual medicine. 2004;1(3):292-300. Epub 2006/01/21.
14. Cheng JY, Ng EM, Chen RY, Ko JS. Prevalence of erectile dysfunction in Asian populations: a meta-analysis. International journal of impotence research. 2007;19(3):229-44. Epub 2006/08/25.
15. Chew KK. Prevalence of erectile dysfunction in communitybased studies. International journal of impotence research. 2004;16(2):201-2. Epub 2004/04/10.
16.  Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. The New England journal of medicine. 1989;320(16):1025-30. Epub 1989/04/20.
17. Kirby M, Jackson G, Betteridge J, Friedli K. Is erectile dysfunction a marker for cardiovascular disease? International journal of clinical practice. 2001;55(9):614-8. Epub 2002/01/05.
18. 13. Hannan JL, Maio MT, Komolova M, Adams MA. Beneficial impact of exercise and obesity interventions on erectile function and its risk factors. The journal of sexual medicine. 2009;6 Suppl 3:254-61. Epub 2009/01/28.
19. Hannan JL, Heaton JP, Adams MA. Recovery of erectile function in aging hypertensive and normotensive rats using exercise and caloric restriction. The journal of sexual medicine. 2007;4(4 Pt 1):886-97. Epub 2007/07/14.
20. Horasanli K, Boylu U, Kendirci M, Miroglu C. Do lifestyle changes work for improving erectile dysfunction? Asian journal of andrology. 2008;10(1):28-35. Epub 2007/12/19.
21. Mannino DM, Klevens RM, Flanders WD. Cigarette smoking: an independent risk factor for impotence? American journal of epidemiology. 1994;140(11):1003-8. Epub 1994/12/01.
22. Guay AT, Perez JB, Heatley GJ. Cessation of smoking rapidly decreases erectile dysfunction. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 1998;4(1):23-6. Epub 2004/07/15.
23. Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED, Jr., et al. Definitions/epidemiology/risk factors for sexual dysfunction. The journal of sexual medicine. 2010;7(4 Pt 2):1598-607. Epub 2010/04/15.
24. Chew KK, Bremner A, Stuckey B, Earle C, Jamrozik K. Alcohol consumption and male erectile dysfunction: an unfounded reputation for risk? The journal of sexual medicine. 2009;6(5):1386- 94. Epub 2009/01/16.
25. Corona G, Rastrelli G, Filippi S, Vignozzi L, Mannucci E, Maggi M. Erectile dysfunction and central obesity: an Italian perspective. Asian journal of andrology. 2014;16(4):581-91. Epub 2014/04/10.
26. Esposito K, Giugliano D. Lifestyle/dietary recommendations for erectile dysfunction and female sexual dysfunction. The Urologic clinics of North America. 2011;38(3):293-301. Epub 2011/07/30.
27. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. Jama. 2004;291(24):2978-84. Epub 2004/06/24.
28. Maio G, Saraeb S, Marchiori A. Physical activity and PDE5 inhibitors in the treatment of erectile dysfunction: results of a randomized controlled study. The journal of sexual medicine. 2010;7(6):2201-8. Epub 2010/04/07.
29. Melnik T, Althof S, Atallah AN, Puga ME, Glina S, Riera R. Psychosocial interventions for premature ejaculation. The Cochrane database of systematic reviews. 2011(8):CD008195. Epub 2011/08/13.
30. Hawton K, Catalan J, Martin P, Fagg J. Long-term outcome of sex therapy. Behaviour research and therapy. 1986;24(6):665-75. Epub 1986/01/01.
31. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. The New England journal of medicine. 1998;338(20):1397-404. Epub 1998/05/15.
32. Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. International journal of impotence research. 2001;13(4):192-9. Epub 2001/08/09.
33. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. The Journal of urology. 2002;168(4 Pt 1):1332-6. Epub 2002/09/28.
34. Porst H, Giuliano F, Glina S, Ralph R, Adolfo R, Casabe AR et al. Evaluation of the efficacy and safety of once-a day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 2006; 50: 351–9.
35. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. The Journal of urology. 1996;155(3):802-15. Epub 1996/03/01.
36. McMahon CG. Comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine, prostaglandin E1 alone and a combination of all three in the management of impotence. Int J Impotence Res 1991; 3: 133– 42.